Maxim Group Initiates Coverage On Acrivon Therapeutics with Buy Rating, Announces Price Target of $24
Maxim Group analyst Michael Okunewitch initiates coverage on Acrivon Therapeutics (NASDAQ:ACRV) with a Buy rating and announces Price Target of…
Day: October 5, 2023
Footwear Company Caleres Issues 2026 Financial Targets Ahead Of Investor Day Event
Caleres Inc (NYSE:CAL) put forward its three-year strategic and financial plan in conjunction with its Oct. 5 Investor Day. The…
How Is The Market Feeling About Stryker?
Stryker’s (NYSE:SYK) short percent of float has risen 14.29% since its last report. The company recently reported that it has…
(GIS) – Analyzing General Mills’s Short Interest
General Mills’s (NYSE:GIS) short percent of float has fallen 6.91% since its last report. The company recently reported that it…